Savara Pharmaceuticals
SVRA
#7036
Rank
ยฃ0.36 B
Marketcap
ยฃ2.13
Share price
-2.94%
Change (1 day)
-45.85%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -ยฃ64.45 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ44.1 Million a decrease over its 2022 earnings that were of -ยฃ30.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ64.45 Million46.17%
2023 -ยฃ44.1 Million43.38%
2022 -ยฃ30.76 Million-11.31%
2021 -ยฃ34.68 Million-13.3%
2020 -ยฃ40 Million-36.53%
2019 -ยฃ63.02 Million13.76%
2018 -ยฃ55.4 Million105.54%
2017 -ยฃ26.96 Million34.11%
2016 -ยฃ20.1 Million-37.43%
2015 -ยฃ32.12 Million38.81%
2014 -ยฃ23.14 Million33.62%
2013 -ยฃ17.32 Million38.49%
2012 -ยฃ12.51 Million24.59%
2011 -ยฃ10.04 Million-36.5%
2010 -ยฃ15.81 Million-3.14%
2009 -ยฃ16.32 Million-23.28%
2008 -ยฃ21.27 Million8.52%
2007 -ยฃ19.6 Million-34.14%
2006 -ยฃ29.76 Million184.43%
2005 -ยฃ10.47 Million90.75%
2004 -ยฃ5.49 Million190.35%
2003 -ยฃ1.89 Million11.64%
2002 -ยฃ1.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ14.64 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ95 Million 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA